DE69734242D1 - Wassermischbare erythromycin-zusammensetzungen - Google Patents

Wassermischbare erythromycin-zusammensetzungen

Info

Publication number
DE69734242D1
DE69734242D1 DE69734242T DE69734242T DE69734242D1 DE 69734242 D1 DE69734242 D1 DE 69734242D1 DE 69734242 T DE69734242 T DE 69734242T DE 69734242 T DE69734242 T DE 69734242T DE 69734242 D1 DE69734242 D1 DE 69734242D1
Authority
DE
Germany
Prior art keywords
mixable
water
erythromycin
erythromycin compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69734242T
Other languages
English (en)
Other versions
DE69734242T2 (de
Inventor
E Hopponen
R Macy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merial Ltd
Merial LLC
Original Assignee
Merial Ltd
Merial LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd, Merial LLC filed Critical Merial Ltd
Application granted granted Critical
Publication of DE69734242D1 publication Critical patent/DE69734242D1/de
Publication of DE69734242T2 publication Critical patent/DE69734242T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)
DE69734242T 1996-07-02 1997-07-02 Wassermischbare erythromycin-zusammensetzungen Expired - Lifetime DE69734242T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US675380 1991-03-26
US08/675,380 US5723447A (en) 1996-07-02 1996-07-02 Water miscible erythromycin solutions
PCT/US1997/011460 WO1998000146A1 (en) 1996-07-02 1997-07-02 Water miscible erythromycin solutions

Publications (2)

Publication Number Publication Date
DE69734242D1 true DE69734242D1 (de) 2005-10-27
DE69734242T2 DE69734242T2 (de) 2006-01-26

Family

ID=24710231

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69734242T Expired - Lifetime DE69734242T2 (de) 1996-07-02 1997-07-02 Wassermischbare erythromycin-zusammensetzungen

Country Status (13)

Country Link
US (1) US5723447A (de)
EP (1) EP0925065B1 (de)
JP (1) JP2000516205A (de)
AT (1) ATE304857T1 (de)
AU (1) AU717148B2 (de)
BR (1) BR9710118B1 (de)
CA (1) CA2259430C (de)
DE (1) DE69734242T2 (de)
DK (1) DK0925065T3 (de)
ES (1) ES2246515T3 (de)
NZ (1) NZ333574A (de)
PT (1) PT925065E (de)
WO (1) WO1998000146A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958888A (en) * 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6780885B1 (en) * 2000-01-14 2004-08-24 Idexx Laboratories, Inc. Formulations and methods for administration of pharmacologically or biologically active compounds
US6914051B1 (en) * 2000-06-28 2005-07-05 David M Allen Penetrating antibiotic gel for soft tissue diseases
AU2001280000A1 (en) * 2000-08-23 2002-03-04 Jaweed Mukarram, Siddiqui Mohammed Process for preparation of anhydrous azithromycin
BRPI0213425B8 (pt) * 2001-10-19 2021-05-25 Idexx Lab Inc composições injetáveis para a liberação controlada de composto farmacologicamente ativo, usos do referido composto e método para suas preparações
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
US20050049209A1 (en) * 2003-08-06 2005-03-03 Chen Andrew Xian Pharmaceutical compositions for delivering macrolides
US20050049210A1 (en) * 2003-08-27 2005-03-03 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
US7282487B2 (en) * 2004-10-28 2007-10-16 Idexx Laboratories Method for treating bacterial infections in horses or pigs with tilmicosin
EP1845860B1 (de) 2005-11-22 2009-03-11 Omrix Biopharmaceuticals S.A. Applikatorvorrichtung zum aufbringen einer mehrkomponenten-flüssigkeit
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795492B (en) * 1978-10-20 1981-05-27 Lilly Co Eli Stable erythromycin solution
US4264765A (en) * 1980-02-20 1981-04-28 Abbott Laboratories Salts of erythromycin A esters
US5175150A (en) * 1985-08-31 1992-12-29 Kitasato, Kenkyusho Erythromycin derivative
DE19518917A1 (de) * 1995-05-23 1996-11-28 Boehringer Ingelheim Vetmed Stabile, konzentrierte lokalverträgliche Erythromycylamin-Lösungen

Also Published As

Publication number Publication date
ATE304857T1 (de) 2005-10-15
DK0925065T3 (da) 2005-10-17
EP0925065A1 (de) 1999-06-30
CA2259430A1 (en) 1998-01-08
WO1998000146A1 (en) 1998-01-08
US5723447A (en) 1998-03-03
NZ333574A (en) 2000-03-27
BR9710118A (pt) 2000-01-18
EP0925065A4 (de) 2000-05-10
AU717148B2 (en) 2000-03-16
ES2246515T3 (es) 2006-02-16
BR9710118B1 (pt) 2010-02-23
EP0925065B1 (de) 2005-09-21
JP2000516205A (ja) 2000-12-05
PT925065E (pt) 2005-11-30
DE69734242T2 (de) 2006-01-26
AU3512497A (en) 1998-01-21
CA2259430C (en) 2008-11-18

Similar Documents

Publication Publication Date Title
CA2336809A1 (en) Water miscible macrolide solutions
DE69734242D1 (de) Wassermischbare erythromycin-zusammensetzungen
ES2183847T3 (es) Composiciones a base de agua que contienen organopolisiloxano, procedimiento para su elaboracion y su uso.
AR030045A1 (es) Composicion farmaceutica que contiene compuestos antibioticos de azalida , metodos para obtencion
CA2412541A1 (en) 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-.beta.-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group
AU3104300A (en) Solvent resistant photosensitive compositions
ES2125535T5 (es) Mezclas, que contienen isocianatos emulsionables en agua.
ES2147376T3 (es) Composicion de electrolito polimero basada en la quimica de los tiol-enos.
BR9407052A (pt) Misturas de combustiveis
ES2161201T1 (es) Derivado de benzamida, composiciones que contienen dicho derivado y su empleo.
NO20030182L (no) Dermalt påföringssystem for aminolevulinsyre
DK314289D0 (da) Kompositioner
EP0798383A3 (de) Methode zur Herstellung einer Esterverbindung mit Hilfe eines Enzyms in Lösungsmittelfreier Phase
ES2174323T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
GB1433308A (en) Acetamidophenyl esters of salicylic acid derivatives
JPS5424837A (en) Selective hyerogenation of aromatic nitro compound
ID16017A (id) Proses yang dimanfaatkan untuk memproduksi asam organik
PT859795E (pt) Processo para a preparacao de ferro-dextrano cristalino
FR2701482B1 (fr) Nouveaux composés de type pipéridine-triazine appropriés en tant que stabilisateurs de matières organiques.
FI810431L (fi) Foerfarande foer framstaellning av 3'-bromsubstituerade deacetoxicefalosporansyrasulfoxidderivat
DE69920039D1 (de) Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung
RU95112573A (ru) Способ получения 9-аминокамптотецина, промежуточные продукты, способ их получения и фармкомпозиция
CA2098959A1 (en) Compounds and methods for the site-specific photoaffinity labelling of biomolecules
ATE206048T1 (de) Zur topischen applikation bestimmte diclofenac- lösung
JPS5412369A (en) Preparation of thienylacetic acid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition